Status:
COMPLETED
The Effect of Complex Decongestive Therapy in Patients With Lymphedema
Lead Sponsor:
Medipol University
Conditions:
Lymphedema
Urine Marking
Eligibility:
FEMALE
30-60 years
Phase:
NA
Brief Summary
The aim of this study is to investigate objectively the effect of lymphatic fluid which is circulated with Complex Decongestive Therapy on fluid excretion from the body in patients with lymphedema.
Detailed Description
The lymphatic system is the accessory circulatory system that takes lymph fluid from the interstitial space and adds it to the blood circulation. It starts from the interstitial space. It consists of ...
Eligibility Criteria
Inclusion
- Female cases
- Cases diagnosed with lower extremity unilateral/bilateral lymphedema
- Having received or not received radiotherapy and/or chemotherapy
Exclusion
- Having received treatment for lymphedema in the last year
- Having metastatic disease
- Those diagnosed with severe heart failure and/or arrhythmia
- Arterial disorders
- Kidney diseases
- Infection in affected extremities
- Psychological disorders
- Diabetes
- Nephrotic syndrome
- Diuretic use
- Patients using chemotherapy and drugs that have toxic effects on the kidneys
- Those with liver cirrhosis, liver disease
- Neurological diseases
Key Trial Info
Start Date :
September 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06220903
Start Date
September 1 2018
End Date
June 30 2019
Last Update
January 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul Medipol University
Istanbul, Beykoz, Turkey (Türkiye), 34100